Purchases and Sales Made in Q2 2024 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q2 2024. The information is specifically focused on institutions that hold shares of Revance Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 09, 2024
Q2 2024
|
Cibc Private Wealth Group, LLC
|
SELL
|
- |
-4.66K- 97.1% |
$10.9K - $22K
|
139
$357
|
|
Jul 19, 2024
Q2 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-4.71K- 27.74% |
$11K - $22.3K
|
12.3K
$31.5K
|
|
Aug 13, 2024
Q2 2024
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-6.95K- 0.05% |
$16.3K - $32.9K
|
13.9M
$35.8M
|
|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-8.37K- 18.42% |
$19.6K - $39.6K
|
37.1K
$95.2K
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-11.3K- 1.82% |
$26.5K - $53.6K
|
611K
$1.57M
|
|
Aug 14, 2024
Q2 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-12K- 14.4% |
$28K - $56.6K
|
71.2K
$183K
|
|
Aug 14, 2024
Q2 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-12.3K- 17.81% |
$28.8K - $58.2K
|
56.8K
$146K
|
|
Aug 12, 2024
Q2 2024
|
Dcf Advisers, LLC
Greenwich, CT |
SELL
|
- |
-13.4K- 5.08% |
$31.3K - $63.2K
|
250K
$643K
|
|
Aug 14, 2024
Q2 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-24.5K- 0.39% |
$57.3K - $116K
|
6.26M
$16.1M
|
|
Aug 14, 2024
Q2 2024
|
Gts Securities LLC
New York, NY |
SELL
|
- |
-28.7K- 72.49% |
$67.2K - $136K
|
10.9K
$28K
|
|
Aug 14, 2024
Q2 2024
|
Nebula Research & Development LLC
New York, NY |
SELL
|
- |
-30.5K- 17.44% |
$71.4K - $144K
|
144K
$371K
|
|
Aug 07, 2024
Q2 2024
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-34.1K- 4.57% |
$79.7K - $161K
|
712K
$1.83M
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-34.5K- 91.71% |
$80.7K - $163K
|
3.12K
$8.01K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-35.6K- 58.82% |
$83.3K - $168K
|
24.9K
$64K
|
|
Aug 12, 2024
Q2 2024
|
Blair William & CO
Chicago, IL |
SELL
|
- |
-38.8K- 11.77% |
$90.7K - $183K
|
291K
$747K
|
|
Aug 14, 2024
Q2 2024
|
Sherbrooke Park Advisers LLC
White Plains, NY |
SELL
|
- |
-58.1K- 79.06% |
$136K - $275K
|
15.4K
$39.6K
|
|
Aug 14, 2024
Q2 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-66.3K- 69.98% |
$155K - $314K
|
28.4K
$73.1K
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-75.1K- 3.19% |
$176K - $355K
|
2.28M
$5.87M
|
|
Aug 13, 2024
Q2 2024
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-87.3K- 51.36% |
$204K - $413K
|
82.7K
$213K
|
|
Aug 14, 2024
Q2 2024
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-127K- 92.71% |
$298K - $602K
|
10K
$25.7K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-139K- 73.3% |
$326K - $659K
|
50.8K
$130K
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-190K- 63.78% |
$445K - $899K
|
108K
$278K
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-208K- 6.6% |
$487K - $985K
|
2.94M
$7.57M
|
|
Aug 14, 2024
Q2 2024
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-225K- 50.0% |
$527K - $1.06M
|
225K
$578K
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-227K- 18.84% |
$531K - $1.07M
|
977K
$2.51M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-227K- 18.84% |
$531K - $1.07M
|
977K
$2.51M
|
|
Aug 14, 2024
Q2 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-318K- 8.18% |
$743K - $1.5M
|
3.57M
$9.17M
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-325K- 64.34% |
$760K - $1.54M
|
180K
$462K
|
|
Aug 14, 2024
Q2 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-1.54M- 96.35% |
$3.61M - $7.29M
|
58.4K
$150K
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-2.98M- 98.76% |
$6.98M - $14.1M
|
37.3K
$96K
|